Hino, Japan

Masato Komiyama



 

Average Co-Inventor Count = 2.1

ph-index = 1


Location History:

  • Tokyo, JP (2014)
  • Hino, JP (2015)

Company Filing History:


Years Active: 2014-2015

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Masato Komiyama: Innovator in Pharmaceutical Chemistry

Introduction

Masato Komiyama is a notable inventor based in Hino, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of therapeutic agents. With a total of 3 patents to his name, Komiyama's work focuses on innovative solutions for health-related challenges.

Latest Patents

Among his latest patents, one includes a novel vitamin D derivative that serves as a therapeutic agent for osteoporosis. This vitamin D derivative is represented by a specific formula, which is designed to enhance treatment options for patients suffering from this condition. Another significant patent involves a process for producing phenyl-substituted heterocyclic derivatives through coupling using a transition metal catalyst. This process efficiently produces either a xanthine oxidase inhibitor, which is beneficial for treating hyperuricemia, or an intermediate compound necessary for its synthesis.

Career Highlights

Masato Komiyama is currently associated with Teijin Pharma Limited, where he continues to advance his research and development efforts. His work has been instrumental in creating innovative pharmaceutical solutions that address critical health issues.

Collaborations

Throughout his career, Komiyama has collaborated with esteemed colleagues, including Hiroshi Saito and Eiji Ochiai. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

Masato Komiyama's contributions to pharmaceutical chemistry exemplify the importance of innovation in developing effective therapeutic agents. His ongoing work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…